Howard L. Parnes - Concepedia

Author

Howard L. Parnes

Also Known As

H L Parnes, H Parnes, H. L. Parnes, H. PARNES, H. Parnes, H.L. Parnes, HOWARD L. PARNES, HOWARD PARNES, Howard L Parnes, Howard L. Parnes

349

Publications

20.4K

Citations

H-Index

103

Concepts

All Affiliations

National Cancer Institute National Institutes of Health The University of Texas Health Science Center at San Antonio Center for Cancer Research Fred Hutch Cancer Center

About

Howard L. Parnes is an author at National Cancer Institute specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	44	2.8K
2	Health Sciences	12	14	635
3	Public Health	8	8	576
4	Engineering	5	5	220
5	Natural Sciences	3	3	34

Howard L. Parnes

129

Publications

18.5K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter Ian M. Thompson, Donna K. Pauler, Phyllis J. Goodman, New England Journal of Medicine	2004	2.4K
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, JAMA	2008	2.1K
Vitamin E and the Risk of Prostate Cancer Eric A. Klein, Ian M. Thompson, Catherine M. Tangen, JAMA	2011	1.7K
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer Mohummad Minhaj Siddiqui, Soroush Rais‐Bahrami, Barış Türkbey, JAMA	2015	1.5K
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial Ian M. Thompson, Donna P. Ankerst, Chi Chen, JNCI Journal of the National Cancer Institute	2006	936
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis Michael Ahdoot, Andrew R. Wilbur, Sarah E. Reese, New England Journal of Medicine	2020	835
Addressing overdiagnosis and overtreatment in cancer: a prescription for change Laura J. Esserman, Ian M. Thompson, Brian J. Reid, The Lancet Oncology OncologyCancer LiteracyHealth PolicyCancer ManagementCancer Treatment	2014	491
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Scott M. Lippman, Phyllis J. Goodman, Eric A. Klein, JNCI Journal of the National Cancer Institute Chemoprevention StrategyCancer ManagementEpidemiology Of CancerPopulation Health SciencesPharmacotherapy	2005	355
Randomized Phase II Trial of Docetaxel Plus Thalidomide in Androgen-Independent Prostate Cancer William L. Dahut, James L. Gulley, Philip M. Arlen, Journal of Clinical Oncology	2004	350
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen, The Lancet Oncology UrologyMedicineVaccine TargetImmunologyTherapeutic Vaccine	2012	327

Page 1